1-204530752-A-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_002393.5(MDM4):c.222A>T(p.Val74Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00827 in 1,614,198 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0073 ( 8 hom., cov: 33)
Exomes 𝑓: 0.0084 ( 65 hom. )
Consequence
MDM4
NM_002393.5 synonymous
NM_002393.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.28
Genes affected
MDM4 (HGNC:6974): (MDM4 regulator of p53) This gene encodes a nuclear protein that contains a p53 binding domain at the N-terminus and a RING finger domain at the C-terminus, and shows structural similarity to p53-binding protein MDM2. Both proteins bind the p53 tumor suppressor protein and inhibit its activity, and have been shown to be overexpressed in a variety of human cancers. However, unlike MDM2 which degrades p53, this protein inhibits p53 by binding its transcriptional activation domain. This protein also interacts with MDM2 protein via the RING finger domain, and inhibits the latter's degradation. So this protein can reverse MDM2-targeted degradation of p53, while maintaining suppression of p53 transactivation and apoptotic functions. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 1-204530752-A-T is Benign according to our data. Variant chr1-204530752-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 774283.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.28 with no splicing effect.
BS2
High AC in GnomAd4 at 1110 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00729 AC: 1109AN: 152212Hom.: 7 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1109
AN:
152212
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00663 AC: 1667AN: 251482 AF XY: 0.00660 show subpopulations
GnomAD2 exomes
AF:
AC:
1667
AN:
251482
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00837 AC: 12240AN: 1461868Hom.: 65 Cov.: 31 AF XY: 0.00819 AC XY: 5957AN XY: 727232 show subpopulations
GnomAD4 exome
AF:
AC:
12240
AN:
1461868
Hom.:
Cov.:
31
AF XY:
AC XY:
5957
AN XY:
727232
Gnomad4 AFR exome
AF:
AC:
71
AN:
33480
Gnomad4 AMR exome
AF:
AC:
134
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
10
AN:
26132
Gnomad4 EAS exome
AF:
AC:
1
AN:
39692
Gnomad4 SAS exome
AF:
AC:
82
AN:
86258
Gnomad4 FIN exome
AF:
AC:
847
AN:
53420
Gnomad4 NFE exome
AF:
AC:
10668
AN:
1112000
Gnomad4 Remaining exome
AF:
AC:
399
AN:
60394
Heterozygous variant carriers
0
665
1330
1995
2660
3325
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
374
748
1122
1496
1870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00729 AC: 1110AN: 152330Hom.: 8 Cov.: 33 AF XY: 0.00790 AC XY: 588AN XY: 74474 show subpopulations
GnomAD4 genome
AF:
AC:
1110
AN:
152330
Hom.:
Cov.:
33
AF XY:
AC XY:
588
AN XY:
74474
Gnomad4 AFR
AF:
AC:
0.00245334
AN:
0.00245334
Gnomad4 AMR
AF:
AC:
0.0067965
AN:
0.0067965
Gnomad4 ASJ
AF:
AC:
0.000576037
AN:
0.000576037
Gnomad4 EAS
AF:
AC:
0.000385356
AN:
0.000385356
Gnomad4 SAS
AF:
AC:
0.000827815
AN:
0.000827815
Gnomad4 FIN
AF:
AC:
0.0173519
AN:
0.0173519
Gnomad4 NFE
AF:
AC:
0.00971573
AN:
0.00971573
Gnomad4 OTH
AF:
AC:
0.00851466
AN:
0.00851466
Heterozygous variant carriers
0
57
113
170
226
283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
MDM4: BP4, BP7, BS2 -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 04, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=99/1
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at